Literature DB >> 22091

Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects.

M C Oon, R M Murray, R Rodnight, M P Murphy, J L Birley.   

Abstract

The hallucinogenic substance N',N'-dimethyltryptamine and its precursor N-methyltryptamine were found in 24-h specimens of urine from 19 normal human subjects; the mean excretion rates were 386 ng 24 h(-1) and 856 ng 24 h(-1) respectively. The urinary excretion of both compounds was unrelated to age, sex, urinary volume, or creatinine, nor was any consistent diurnal pattern observed. Rates for the mono and dimethylated compounds were not correlated. Diet and the intestinal flora were excluded as a source of urinary dimethyltryptamine. Administration to 4 subjects of sufficient ammonium chloride to increase the H ion concentration of the urine caused a transient increase in dimethyltryptamine excretion but no consistent increase in the rate for N-methyltryptamine. Acidification of the urine did not appear to be the determining factor in this result since in one subject the same drop in urinary pH was achieved by feeding methionine without any increase in dimethyltryptamine excretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 22091     DOI: 10.1007/BF00426775

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  5-Methyltetrahydrofolate aromatic alkylamine N-methyltransferase: an artefact of 5,10-methylenetetrahydrofolate reductase activity.

Authors:  R T Taylor; M L Hanna
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

2.  A test of the transmethylation hypothesis in acute schizophrenic patients.

Authors:  W T Carpenter; E B Fink; N Narasimhachari; H E Himwich
Journal:  Am J Psychiatry       Date:  1975-10       Impact factor: 18.112

3.  Biogenesis of 5-methoxy-N,N-dimethyltryptamine in human pineal gland.

Authors:  R B Guchhait
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

4.  A gas chromatographic procedure for determining N, N-dimethyltryptamine and N-monomethyltryptamine in urine using a nitrogen detector.

Authors:  M C Oon; R Rodnight
Journal:  Biochem Med       Date:  1977-12

5.  Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects.

Authors:  J Kaplan; L R Mandel; R Stillman; R W Walker; W J VandenHeuvel; J C Gillin; R J Wyatt
Journal:  Psychopharmacologia       Date:  1974

6.  Proceedings: Dimethyltryptamine: its biosynthesis and possible role in mental disease.

Authors:  L R Mandel
Journal:  Psychopharmacol Bull       Date:  1974-07

7.  The distribution and properties of the nonspecific N-methyltransferase in brain.

Authors:  J M Saavedra; J T Coyle; J Axelrod
Journal:  J Neurochem       Date:  1973-03       Impact factor: 5.372

8.  N,N-dimethylated indoleamines in blood.

Authors:  N Narasimhachari; B Heller; J Spaide; L Haskovec; H Meltzer; M Strahilevitz; H E Himwich
Journal:  Biol Psychiatry       Date:  1971       Impact factor: 13.382

9.  Effects of urinary pH on amphetamine metabolism.

Authors:  J M Davis; I J Kopin; L Lemberger; J Axelrod
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

10.  Dimethyltryptamine levels in blood of schizophrenic patients and control subjects.

Authors:  B Angrist; S Gershon; G Sathananthan; R W Walker; B Lopez-Ramos; L R Mandel; W J Vandenheuvel
Journal:  Psychopharmacology (Berl)       Date:  1976-05-05       Impact factor: 4.530

View more
  6 in total

Review 1.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

2.  Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.

Authors:  D Ruffing; B Kovacic; S Demetriou; E F Domino
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

Review 3.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

Review 4.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

5.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Authors:  Nicholas V Cozzi; Anupama Gopalakrishnan; Lyndsey L Anderson; Joel T Feih; Alexander T Shulgin; Paul F Daley; Arnold E Ruoho
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

6.  Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.

Authors:  Uyen B Chu; Sevahn K Vorperian; Kenneth Satyshur; Kelsey Eickstaedt; Nicholas V Cozzi; Timur Mavlyutov; Abdol R Hajipour; Arnold E Ruoho
Journal:  Biochemistry       Date:  2014-04-28       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.